Raymond James & Associates’s Exponent EXPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $58.5M | Buy |
507,562
+20,527
| +4% | +$2.15M | 0.04% | 401 |
|
|
2024
Q2 | $46.3M | Buy |
487,035
+19,051
| +4% | +$1.72M | 0.03% | 432 |
|
|
2024
Q1 | $38.7M | Buy |
467,984
+957
| +0.2% | +$79.2K | 0.03% | 487 |
|
|
2023
Q4 | $41.1M | Sell |
467,027
-17,461
| -4% | -$1.43M | 0.03% | 451 |
|
|
2023
Q3 | $41.5M | Buy |
484,488
+10,046
| +2% | +$909K | 0.03% | 408 |
|
|
2023
Q2 | $44.3M | Buy |
474,442
+5,387
| +1% | +$507K | 0.04% | 393 |
|
|
2023
Q1 | $46.8M | Buy |
469,055
+18,842
| +4% | +$1.92M | 0.04% | 379 |
|
|
2022
Q4 | $44.6M | Buy |
450,213
+12,081
| +3% | +$1.17M | 0.04% | 381 |
|
|
2022
Q3 | $38.4M | Buy |
438,132
+231,882
| +112% | +$22M | 0.04% | 392 |
|
|
2022
Q2 | $18.9M | Sell |
206,250
-33,101
| -14% | -$3.12M | 0.02% | 643 |
|
|
2022
Q1 | $25.9M | Sell |
239,351
-108,315
| -31% | -$10.4M | 0.02% | 584 |
|
|
2021
Q4 | $40.6M | Buy |
347,666
+18,223
| +6% | +$2.14M | 0.03% | 447 |
|
|
2021
Q3 | $37.3M | Buy |
329,443
+38,729
| +13% | +$4.18M | 0.03% | 443 |
|
|
2021
Q2 | $25.9M | Buy |
290,714
+20,910
| +8% | +$1.96M | 0.02% | 581 |
|
|
2021
Q1 | $26.3M | Buy |
269,804
+6,354
| +2% | +$596K | 0.03% | 540 |
|
|
2020
Q4 | $23.7M | Buy |
263,450
+76,770
| +41% | +$6.12M | 0.03% | 545 |
|
|
2020
Q3 | $13.4M | Buy |
186,680
+33,509
| +22% | +$2.66M | 0.02% | 711 |
|
|
2020
Q2 | $12.4M | Buy |
153,171
+100,851
| +193% | +$7.26M | 0.02% | 720 |
|
|
2020
Q1 | $3.76M | Buy |
52,320
+993
| +2% | +$72.1K | 0.01% | 1200 |
|
|
2019
Q4 | $3.54M | Buy |
51,327
+785
| +2% | +$51.8K | ﹤0.01% | 1479 |
|
|
2019
Q3 | $3.53M | Sell |
50,542
-5,874
| -10% | -$396K | ﹤0.01% | 1437 |
|
|
2019
Q2 | $3.3M | Sell |
56,416
-259
| -0.5% | -$14.7K | ﹤0.01% | 1489 |
|
|
2019
Q1 | $3.27M | Buy |
56,675
+1,182
| +2% | +$63.9K | 0.01% | 1451 |
|
|
2018
Q4 | $2.81M | Sell |
55,493
-8,062
| -13% | -$404K | ﹤0.01% | 1435 |
|
|
2018
Q3 | $3.41M | Buy |
63,555
+833
| +1% | +$42.7K | 0.01% | 1460 |
|
|
2018
Q2 | $3.03M | Buy |
62,722
+462
| +0.7% | +$21.2K | 0.01% | 1494 |
|
|
2018
Q1 | $2.45M | Buy |
62,260
+5,508
| +10% | +$208K | ﹤0.01% | 1582 |
|
|
2017
Q4 | $2.02M | Buy |
56,752
+4,422
| +8% | +$162K | ﹤0.01% | 1686 |
|
|
2017
Q3 | $1.93M | Buy |
52,330
+2,674
| +5% | +$88.3K | ﹤0.01% | 1671 |
|
|
2017
Q2 | $1.45M | Buy |
49,656
+280
| +0.6% | +$8.37K | ﹤0.01% | 1795 |
|
|
2017
Q1 | $1.47M | Sell |
49,376
-91,434
| -65% | -$2.66M | ﹤0.01% | 1733 |
|
|
2016
Q4 | $4.25M | Sell |
140,810
-292
| -0.2% | -$8.47K | 0.01% | 1072 |
|
|
2016
Q3 | $3.6M | Sell |
141,102
-16,834
| -11% | -$439K | 0.01% | 1115 |
|
|
2016
Q2 | $4.61M | Buy |
157,936
+7,744
| +5% | +$201K | 0.01% | 892 |
|
|
2016
Q1 | $3.83M | Sell |
150,192
-7,152
| -5% | -$173K | 0.01% | 961 |
|
|
2015
Q4 | $3.93M | Buy |
157,344
+96,830
| +160% | +$2.46M | 0.01% | 919 |
|
|
2015
Q3 | $1.35M | Sell |
60,514
-22
| -0% | -$484 | 0.01% | 1440 |
|
|
2015
Q2 | $1.35M | Sell |
60,536
-7,192
| -11% | -$158K | 0.01% | 1562 |
|
|
2015
Q1 | $1.5M | Buy |
67,728
+21,160
| +45% | +$453K | 0.01% | 1415 |
|
|
2014
Q4 | $960K | Buy |
46,568
+5,132
| +12% | +$99.5K | ﹤0.01% | 1607 |
|
|
2014
Q3 | $734K | Buy |
+41,436
| New | +$761K | ﹤0.01% | 1678 |
|
Other funds holding EXPO
CCA
GCM
Raymond James & Associates's EXPO Position: Q3 2024 in Review
Raymond James & Associates increased its Exponent (EXPO) stake by 4.2% in Q3 2024, buying an estimated $2.15M and bringing the position to 507,562 shares worth $58.5M. The position accounts for 0.04% of the portfolio, ranked #401.
Raymond James & Associates first reported a position in EXPO in Q3 2014 and has held it in 41 quarters since. 373 funds tracked by Wall St. Rank hold EXPO as of Q3 2024.
- Raymond James & Associates held 507,562 shares of Exponent worth $58.5M as of Q3 2024.
- Raymond James & Associates bought 20,527 Exponent shares in Q3 2024, an estimated $2.15M.
- Exponent made up 0.04% of Raymond James & Associates's portfolio in Q3 2024, its #401 holding.
- Raymond James & Associates first reported a position in Exponent in Q3 2014 and has held it in 41 quarters since.
- 373 funds tracked by Wall St. Rank held Exponent as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.